4-demethoxydaunorubicin ( 4-dmdr ) is an orally active analog of daunorubicin that in preclinical testing has demonstrated greater antitumor activity and less cardiotoxicity than its parent compound .
C0020789
4-dmdr
C0011015
daunorubicin